11 Channing Street
EIP Pharma, LLC is a private company that has licensed-in and is developing VX-745, a phase 2 clinical-stage oral investigational drug that targets neuro-inflammation, dysfunction of microglia (the major immune-cell in the brain) and the effects of inflammation in the brain on neuronal & synaptic function.
Founder and CEO: John Alam
Founder: Sylvie Grégoire
Please click here for clinical trial information.